New drug combo shows promise for lung cancer patients with high mutation levels
NCT ID NCT03836066
First seen Jan 08, 2026 · Last updated Apr 29, 2026 · Updated 20 times
Summary
This study tested a combination of two drugs, atezolizumab and bevacizumab, as a first treatment for people with advanced non-squamous non-small cell lung cancer that has high tumor mutations. The goal was to see if this combination could stop the cancer from growing. The study involved 41 participants and measured how long they lived without the cancer getting worse.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON SMALL CELL LUNG CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Complejo Hospitalario Universitario A Coruña
A Coruña, La Coruña, 15006, Spain
-
Complejo Hospitalario de Jaén
Jaén, Jaén, 23007, Spain
-
Complejo Hospitalario de Toledo
Toledo, Toledo, 45004, Spain
-
Complexo Hospitalario Universitario de Vigo
Vigo, Pontevedra, 36036, Spain
-
Consorci Sanitari de Terrassa
Terrassa, Barcelona, 08022, Spain
-
Consorcio Hospitalario Provincial de Castelló
Castelló, Castelló, 12004, Spain
-
Hospital Clínic de Barcelona
Barcelona, Barcelona, 08036, Spain
-
Hospital Clínico San Carlos
Madrid, Madrid, 28040, Spain
-
Hospital Clínico Universitario de Santiago
Santiago de Compostela, A Coruña, 15706, Spain
-
Hospital Clínico Universitario de Valencia
Valencia, Valencia, 46010, Spain
-
Hospital Clínico Universitario de Valladolid
Valladolid, Valladolid, 47003, Spain
-
Hospital General Universitario de Elche
Elche, Alicante, 03203, Spain
-
Hospital General Universitario de Málaga
Málaga, Málaga, 29010, Spain
-
Hospital General de Alicante
Alicante, Alicante, 03010, Spain
-
Hospital General de Valencia
Valencia, Valencia, 46014, Spain
-
Hospital La Princesa
Madrid, Madrid, 28006, Spain
-
Hospital Puerta de Hierro
Majadahonda, Madrid, 28222, Spain
-
Hospital Universitari i Politécnic La Fe
Valencia, Valencia, 46009, Spain
-
Hospital Universitario Fundación Jiménez Díaz
Madrid, Madrid, 28040, Spain
-
Hospital Universitario Lucus Augusti
Lugo, Lugo, 27003, Spain
-
Hospital Universitario Reina Sofía
Córdoba, Córdoba, 14004, Spain
-
Hospital Universitario Son Espases
Palma de Mallorca, Mallorca, 07120, Spain
-
Hospital Universitario Son Llàtzer
Palma de Mallorca, Mallorca, 07198, Spain
-
Hospital de la Santa Creu i Sant Pau
Barcelona, Barcelona, 08041, Spain
-
ICO Badalona
Badalona, Barcelona, 08916, Spain
Conditions
Explore the condition pages connected to this study.